Griggs J, Weiss M
Oral solid-form research compound formulated for controlled analytical and investigational applications
Coupled with other factors that reduce glutathione levelschronic illness, stress, aging, GMO foods and certain pharmaceuticals, your liver cannot keep up with the detoxification demands and production of glutathione
If tolerated with minimal side effects, increase by 0.05mg every 4-6 weeks based on how your body responds
It is currently the only compound of its kind that has received FDA approval (under the name Vyleesi) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, further highlighting its importance as a research molecule
Originally discovered in human plasma in the 1970s, GHK-Cu is recognized for its roles in wound healing, collagen synthesis, and tissue repair